iData Insights

Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015 Now Available at iData Insights

News   •   Jan 29, 2016 12:52 IST

vThis report provides top line data relating to the clinical trials on Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe.

Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level *Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Browse Complete Report with TOC http://www.idatainsights.com/reports-landing-page.php?id=173467/chronic-coronary-artery-disease-cad-ischemic-heart-disease-global-clinical-trials-review-h2-2015

To Get Sample Copy of Report visit http://www.idatainsights.com/reports-landing-page.php?id=173467/chronic-coronary-artery-disease-cad-ischemic-heart-disease-global-clinical-trials-review-h2-2015

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 15

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 20

Clinical Trials by Phase in E7 Countries 22

Clinical Trials in E7 Countries by Trial Status 23

Clinical Trials by Phase 24

In Progress Trials by Phase 25

Clinical Trials by Trial Status 26

Clinical Trials by End Point Status 28

Subjects Recruited Over a Period of Time 29

Clinical Trials by Sponsor Type 30

Prominent Sponsors 31

Top Companies Participating in Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials 33

Prominent Drugs 35

Latest Clinical Trials News on Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) 36

Nov 08, 2015: Isis Pharmaceuticals Reports Positive Clinical Data From Lp(a) Lowering Drug 36

Clinical Trial Profile Snapshots 37

Appendix 95

Abbreviations 95

Definitions 95

Research Methodology 96

Secondary Research 96

About GlobalData 97

Contact Us 97

Disclaimer 97

Source 98

Read More http://www.idatainsights.com/reports-landing-page.php?id=173467/chronic-coronary-artery-disease-cad-ischemic-heart-disease-global-clinical-trials-review-h2-2015

About Us:

iData Insights which operates under Precision Research and Consulting Private Limited is a leading market research information aggregator and marketing research consulting firm. We conduct both primary and secondary research. Our work does not end with research it is also involved in distributing reports for different companies . We provide actionable recommendations and provide our expertise for business success today and tomorrow. It is our goal to be a partner to our clients in the exploration and discovery, and then be their guide in the implementation of changes that will make a difference to their bottom line.

ContactUs:
iData Insights

Tel: 1-866-237-2965

Web: http://www.idatainsights.com
Email: info@idatainsights.com

AboutiData Insights

We work around the clock until our clients are completely satisfied with their promised results. It is our mission to provide timely services coupled with acute client care to create a long-lasting relationship with you. We deliver on our promise to provide results that are essential to the success of your company. We believe that by doing so, we will earn the trust of our clients for future project.